Top Markets
Coin of the day
InDex Pharmaceuticals Holding AB (publ) InDex Pharmaceuticals Holding AB (publ)

InDex Pharmaceuticals Holding AB (publ)

INDEX
Clasificación en acciones #28996
InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to... InDex Pharmaceuticals Holding AB (publ) is a pharmaceutical firm dedicated to developing therapeutic solutions for patients affected by ulcerative colitis. The company's flagship drug candidate, Cobitolimod, is presently in Phase III clinical trials, targeting the treatment of moderate to severe ulcerative colitis. Furthermore, InDex is progressing a pipeline of other DNA-based immunomodulatory sequences, which are in the preclinical phase, designed to address various immunological conditions. This enterprise was established in 2000 and operates from its headquarters in Solna, Sweden.
Precio por acción
$0.04406501
Última sincronización: 2024-07-09
Capitalización bursátil
$23.47M
Cambio (1 día)
-0.48%
Cambio (1 año)
0.00%
País
SE
Comercio InDex Pharmaceuticals Holding AB (publ) (INDEX)

Categoría

Ratio P/B de InDex Pharmaceuticals Holding AB (publ) (INDEX)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de InDex Pharmaceuticals Holding AB (publ), el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de InDex Pharmaceuticals Holding AB (publ) desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
6.3419 -
US
3.7087 -
US
6.2413 -
NL
2.5054 -
AU
- -
CH